相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Depression and coronary heart disease: 2018 position paper of the ESC working group on coronary pathophysiology and microcirculation
Viola Vaccarino et al.
EUROPEAN HEART JOURNAL (2020)
Anti-thrombotic options for secondary prevention in patients with chronic atherosclerotic vascular disease: what does COMPASS add?
K. A. A. Fox et al.
EUROPEAN HEART JOURNAL (2019)
High-Sensitivity Troponin I and Coronary Computed Tomography in Symptomatic Outpatients With Suspected CAD Insights From the PROMISE Trial
James L. Januzzi et al.
JACC-CARDIOVASCULAR IMAGING (2019)
Reassessing the Mechanisms of Acute Coronary Syndromes The Vulnerable Plaque and Superficial Erosion
Peter Libby et al.
CIRCULATION RESEARCH (2019)
Low-Dose Methotrexate for the Prevention of Atherosclerotic Events
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
External applicability of the COMPASS trial: an analysis of the reduction of atherothrombosis for continued health (REACH) registry
Arthur Darmon et al.
EUROPEAN HEART JOURNAL (2018)
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
Marco Valgimigli et al.
EUROPEAN HEART JOURNAL (2018)
High-Sensitivity Cardiac Troponin I and the Diagnosis of Coronary Artery Disease in Patients With Suspected Angina Pectoris
Philip D. Adamson et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2018)
Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology
Petar M. Seferovic et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Long-term efficacy and safety of proprotein convertase subtilisin/kexin 9 monoclonal antibodies: A meta-analysis of 11 randomized controlled trials
Jie Bai et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2018)
Ticagrelor for Secondary Prevention of Atherothrombotic Events in Patients With Multivessel Coronary Disease
Sameer Bansilal et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial
Stuart J. Connolly et al.
LANCET (2018)
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial
Sonia S. Anand et al.
LANCET (2018)
Revascularization in stable coronary disease: evidence and uncertainties
Demosthenes G. Katritsis et al.
NATURE REVIEWS CARDIOLOGY (2018)
High-Sensitivity Cardiac Troponin I and the Diagnosis of Coronary Artery Disease in Patients With Suspected Angina Pectoris
Philip D. Adamson et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2018)
The risk-treatment paradox in non-ST-elevation myocardial infarction patients according to their estimated GRACE risk
Aet Saar et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Coronary CT Angiography and 5-Year Risk of Myocardial Infarction
David E. Newby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
A consensus statement on lipid management after acute coronary syndrome
Francois Schiele et al.
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2018)
Intracoronary Optical Coherence Tomography 2018
Ziad A. Ali et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2017)
Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease
Daniel Lindholm et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention
Erin A. Bohula et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Theo Vos et al.
LANCET (2017)
Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial
E. Magnus Ohman et al.
LANCET (2017)
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
J. W. Eikelboom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
Rury R. Holman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Bruce Neal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Guía ESC/EAS 2016 sobre el tratamiento de las dislipemias
Alberico L. Catapano et al.
REVISTA ESPANOLA DE CARDIOLOGIA (2017)
Are non-ST-segment elevationmyocardial infarctions missing in China?
Karthik Murugiah et al.
EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES (2017)
Cardiac troponins: from myocardial infarction to chronic disease
Kyung Chan Park et al.
CARDIOVASCULAR RESEARCH (2017)
Mitigating Cardiovascular Risk in Type 2 Diabetes With Antidiabetes Drugs: A Review of Principal Cardiovascular Outcome Results of EMPA-REG OUTCOME, LEADER, and SUSTAIN-6 Trials
Sanjay Kaul
DIABETES CARE (2017)
Vorapaxar in patients with coronary artery bypass grafting: Findings from the TRA 2°P-TIMI 50 trial
Ethan C. Kosova et al.
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2017)
Novel Risk Markers and Risk Assessments for Cardiovascular Disease
Mark R. Thomas et al.
CIRCULATION RESEARCH (2017)
Dual pathway therapy in acute coronary syndrome
Peter Stachon et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2016)
Acute Coronary Syndrome: Focus on Antiplatelet Therapy
Rodel V. Bobadilla
CRITICAL CARE NURSE (2016)
Efficacy and safety of edoxaban compared with warfarin in patients with atrial fibrillation and heart failure: insights from ENGAGE AF-TIMI 48
Giulia Magnani et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions A Systematic Review and Meta-analysis
Michael G. Silverman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Reduction in Ischemic Events With Ticagrelor in Diabetic Patients With Prior Myocardial Infarction in PEGASUS-TIMI 54
Deepak L. Bhatt et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Steven P. Marso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Steven P. Marso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis
Nathan R. Hill et al.
PLOS ONE (2016)
Using big data from health records from four countries to evaluate chronic disease outcomes: a study in 114 364 survivors of myocardial infarction
Eleni Rapsomaniki et al.
EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES (2016)
Vorapaxar in Patients With Diabetes Mellitus and Previous Myocardial Infarction Findings From the Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events-TIMI 50 Trial
Matthew A. Cavender et al.
CIRCULATION (2015)
Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death Outcomes at 4 Years From the Reduction of Atherothrombosis for Continued Health (REACH) Registry
Matthew A. Cavender et al.
CIRCULATION (2015)
High Event Rate After a First Percutaneous Coronary Intervention in Patients With Diabetes Mellitus Results From the Swedish Coronary Angiography and Angioplasty Registry
Viveca Ritsinger et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2015)
Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective
Tomas Jernberg et al.
EUROPEAN HEART JOURNAL (2015)
The Myth of the Vulnerable Plaque Transitioning From a Focus on Individual Lesions to Atherosclerotic Disease Burden for Coronary Artery Disease Risk Assessment
Armin Arbab-Zadeh et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Role of high shear rate in thrombosis
Lauren D. C. Casa et al.
JOURNAL OF VASCULAR SURGERY (2015)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
Marc P. Bonaca et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
Christopher P. Cannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Identifying active vascular microcalcification by 18F-sodium fluoride positron emission tomography
Agnese Irkle et al.
NATURE COMMUNICATIONS (2015)
2014 ESC/EACTS Guidelines on myocardial revascularization
Stephan Windecker et al.
EUROINTERVENTION (2015)
PET imaging of atherosclerosis
Jason M. Tarkin et al.
FUTURE CARDIOLOGY (2015)
Prognostic models for stable coronary artery disease based on electronic health record cohort of 102 023 patients
Eleni Rapsomaniki et al.
EUROPEAN HEART JOURNAL (2014)
Platelet function testing to adjust antiplatelet therapy for elective coronary stenting: a landmark analysis of the ARCTIC trial
G. Montalescot et al.
EUROPEAN HEART JOURNAL (2014)
Effect of Darapladib on Major Coronary Events After an Acute Coronary Syndrome The SOLID-TIMI 52 Randomized Clinical Trial
Michelle L. O'Donoghue et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Impact of Chronic Kidney Disease on Use of Evidence-Based Therapy in Stable Coronary Artery Disease: A Prospective Analysis of 22,272 Patients
Paul R. Kalra et al.
PLOS ONE (2014)
Insights into the role of thrombin in the pathogenesis of recurrent ischaemia after acute coronary syndrome
Jeffrey I. Weitz
THROMBOSIS AND HAEMOSTASIS (2014)
Should patients with acute coronary disease be stratified for management according to their risk? Derivation, external validation and outcomes using the updated GRACE risk score
Keith A. A. Fox et al.
BMJ OPEN (2014)
Renal function and short-term outcome in stable outpatients with coronary, cerebrovascular or peripheral artery disease
Davide Bernaudo et al.
ATHEROSCLEROSIS (2013)
Update on acute coronary syndromes: the pathologists view
Erling Falk et al.
EUROPEAN HEART JOURNAL (2013)
Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial
Willem J. M. Dewilde et al.
LANCET (2013)
Chronic Kidney Disease as a Coronary Artery Disease Risk Equivalent
Alexandrios Briasoulis et al.
CURRENT CARDIOLOGY REPORTS (2013)
Coronary Artery Disease in Patients with Chronic Kidney Disease: A Clinical Update
Qiangjun Cai et al.
CURRENT CARDIOLOGY REVIEWS (2013)
Influence of Diabetes Mellitus on Clinical Outcomes Following Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction
Lisette Okkels Jensen et al.
AMERICAN JOURNAL OF CARDIOLOGY (2012)
An International Model to Predict Recurrent Cardiovascular Disease
Peter W. F. Wilson et al.
AMERICAN JOURNAL OF MEDICINE (2012)
Clinical and Angiographic Risk Stratification and Differential Impact on Treatment Outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial
Maria Mori Brooks et al.
CIRCULATION (2012)
Prevalence, Distribution, Predictors, and Outcomes of Patients With Calcified Nodules in Native Coronary Arteries A 3-Vessel Intravascular Ultrasound Analysis From Providing Regional Observations to Study Predictors of Events in the Coronary Tree (PROSPECT)
Yingjia Xu et al.
CIRCULATION (2012)
Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry
Ph Gabriel Steg et al.
EUROPEAN HEART JOURNAL (2012)
Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
Jessica L. Mega et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Vorapaxar in the Secondary Prevention of Atherothrombotic Events
David A. Morrow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Recent Trends in the Incidence, Treatment, and Outcomes of Patients with STEMI and NSTEMI
David D. McManus et al.
AMERICAN JOURNAL OF MEDICINE (2011)
AHA/ACCF Secondary Prevention and Risk REduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 Update - A Guideline from the American Heart Association and American College of Cardiology Foundation
Sidney C. Smith et al.
CIRCULATION (2011)
A Prospective Natural-History Study of Coronary Atherosclerosis.
Gregg W. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome
John H. Alexander et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
A variant at chromosome 9p21 is associated with recurrent myocardial infarction and cardiac death after acute coronary syndrome: The GRACE Genetics Study
Ian Buysschaert et al.
EUROPEAN HEART JOURNAL (2010)
Comparative Determinants of 4-Year Cardiovascular Event Rates in Stable Outpatients at Risk of or With Atherothrombosis
Deepak L. Bhatt et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
The Dynamic Nature of Coronary Artery Lesion Morphology Assessed by Serial Virtual Histology Intravascular Ultrasound Tissue Characterization
Takashi Kubo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Population Trends in the Incidence and Outcomes of Acute Myocardial Infarction.
Robert W. Yeh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Influence of polyvascular disease on cardiovascular event rates. Insights from the REACH Registry
Carmen Suarez et al.
VASCULAR MEDICINE (2010)
Renal function, atherothrombosis extent, and outcomes in high-risk patients
Raphaelle L. Dumaine et al.
AMERICAN HEART JOURNAL (2009)
Contemporary Results Show Repeat Coronary Artery Bypass Grafting Remains a Risk Factor for Operative Mortality
Cheng-Hon Yap et al.
ANNALS OF THORACIC SURGERY (2009)
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
LANCET (2009)
Time course of events in acute coronary syndromes: implications for clinical practice from the GRACE registry
Keith A. A. Fox et al.
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE (2008)
Assessment of culprit lesion morphology in acute myocardial infarction - Ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy
Takashi Kubo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Adjusted indirect meta-analysis of Aspirin plus Warfarin at international normalized ratios 2 to 3 versus Aspirin plus Clopidogrel after acute coronary syndromes
Luca Testa et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial
Deepak L. Bhatt et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
One-year cardiovascular event rates in outpatients with atherothrombosis
Ph. Gabriel Steg et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure
Mihai Gheorghiade et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Navigating the crossroads of coronary artery disease and heart failure
Mihai Gheorghiade et al.
CIRCULATION (2006)
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events
DL Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Morphological characteristics of coronary atherosclerosis in diabetes mellitus
Renu Virmani et al.
CANADIAN JOURNAL OF CARDIOLOGY (2006)
International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis
DL Bhatt et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Risk score for predicting death, myocardial infarction, and stroke in patients with stable angina, based on a large randomised trial cohort of patients
TC Clayton et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
Warfarin plus aspirin after myocardial infarction or the acute coronary syndrome: Meta-analysis with estimates of risk and benefit
MB Rothberg et al.
ANNALS OF INTERNAL MEDICINE (2005)
Pathophysiology of coronary artery disease
P Libby et al.
CIRCULATION (2005)
The prognostic importance of comorbidity for mortality in patients with stable coronary artery disease
M Sachdev et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Benefit of clopidogrel over aspirin is amplified in patients with a history of ischemic events
PA Ringleb et al.
STROKE (2004)
Comparative benefits of clopidogrel and aspirin in high-risk patient populations
J Hirsh et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
From vulnerable plaque to vulnerable patient - A call for new definitions and risk assessment strategies: Part I
M Naghavi et al.
CIRCULATION (2003)
Amplified benefit of Clopidogrel versus aspirin in patients with diabetes mellitus
DL Bhatt et al.
AMERICAN JOURNAL OF CARDIOLOGY (2002)
Extensive development of vulnerable plaques as a pan-coronary process in patients with myocardial infarction: An angioscopic study
M Asakura et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
Lessons from sudden coronary death - A comprehensive morphological classification scheme for atherosclerotic lesions
R Virmani et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
分享论文
